[1] Xue-Quan Zhou*, Selda Abyar, Sylvestre Bonnet*, et al. Multitarget Thiol-Activated Tetrapyridyl Gold(III) Complexes for Hypoxic Cancer Therapy. CCS Chemistry, 2024, 6(3): 783-797.

[2] Xue-Quan Zhou, Alexander Kros, Sylvestre Bonnet*, et al. In vivo metallophilic self-assembly of a light-activated anticancer drug. Nature Chemistry, 2023, 15: 980–987

[3] Xue-Quan Zhou, Sylvestre Bonnet*, et al. Gene therapy of brain cancer by drug delivery nanocapsules. Matter_, 2022, 5(8): 2502-2504.

[4] Xue-Quan Zhou, Sylvestre Bonnet*, et al. Intracellular dynamic assembly of deep-red emitting supramolecular nanostructures based on the Pt…Pt metallophilic interaction. Advanced Materials, 2021, 33(37): 2008613.

[5] Xue-Quan Zhou, Sylvestre Bonnet*, et al. Rollover cyclometalation vs. nitrogen coordination in tetrapyridyl anticancer gold(III) complexes: effect on protein interaction and toxicity. JACS Au, 2021, 1(4) : 380–395.

[6] Xue-Quan Zhou, Sylvestre Bonnet*, et al. The self-assembly of a cyclometalated palladium photosensitizer into proteins-stabilized nanorods triggered drug uptake in vitro and in vivo. Journal of the American Chemical Society, 2020, 142(23) : 10383–10399.

[7] Xue-Quan Zhou, Sylvestre Bonnet*, et al. The two isomers of a cyclometalated palladium sensitizer show different photodynamic properties in cancer cells. Chemical Communications, 2019, 55(32): 4695-4698.

[8] Xue-Quan Zhou^#, Yang Li^# ,Jin-Lei Tian*, et al. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis. European Journal of Medicinal Chemistry, 2016, 114: 244-256.

[9] Xue-Quan Zhou, Jin-Lei Tian*, et al. Synthesis, characterization, DNA/BSA interactions and anticancer activity of achiral and chiral copper complexes. Dalton Transactions, 2015, 44(20): 9516-9527.

[10] Yue Liu, Xue-Quan Zhou*, Jin-Lei Tian*, et al. Biological evaluation of rare earth complexes bearing 1H‐imidazo [4, 5‐f]‐1, 10‐phenanthroline moiety as promising anticancer chemotherapeutics. Applied Organometallic Chemistry, 2018, 32(12): e4617.